Who owns KALA PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Kala Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Kala Pharmaceuticals stock

Who bought or sold KALA PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Baker Bros. Advisors 267k $1.9M 0% Dec 2023
 View chart
Millennium Management 133k $929k -1% Dec 2023
 View chart
Vanguard Group 28k $196k 3% Dec 2023
 View chart
BlackRock 26k $232k -1% Sep 2023
 View chart
Board of Trustees of The Leland Stanford Junior University 21k $148k 0% Dec 2023
 View chart
Geode Capital Management 19k $164k 4% Sep 2023
 View chart
Knights of Columbus Asset Advisors 4.8k $34k 100% Dec 2023
 View chart
Bank of America Corporation 2.6k $18k 2150% Dec 2023
 View chart
Morgan Stanley 1.7k $15k 0% Sep 2023
 View chart
Covestor 1.3k $9.0k -5% Dec 2023
 View chart
Banque Cantonale Vaudoise 808.00 $6.0k 0% Dec 2023
 View chart
UBS Group 696.00 $4.9k 380% Dec 2023
 View chart
Compagnie Lombard, Odier SCA 400.00 $2.8k 0% Dec 2023
 View chart
Citigroup 296.00 $2.1k 0% Dec 2023
 View chart
Advisor Group Holdings 241.00 $1.7k 3% Dec 2023
 View chart
CWM 200.00 $1.0k 0% Dec 2023
 View chart
Steward Partners Investment Advisory 120.00 $840.000000 0% Dec 2023
 View chart
Royal Bank of Canada 63.00 $0 350% Dec 2023
 View chart
Jpmorgan Chase & Co 31.00 $217.000000 0% Dec 2023
 View chart
Wells Fargo & Company 17.00 $119.000000 6% Dec 2023
 View chart
Qube Research & Technologies 3.00 $27.000000 100% Sep 2023
 View chart
Group One Trading 3.00 $27.000000 0% Sep 2023
 View chart

Who sold out of Kala Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Dimensional Fund Advisors Sep 2023 12k $108k
Tower Research Capital Jun 2023 166.00 $2.4k
Parkside Financial Bank & Trust Sep 2023 38.00 $339.001800